|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.48 GBX | +0.38% |
|
-.--% | - |
| 01-13 | Primary Health Properties hikes quarterly dividend after Assura deal | AN |
| 01-05 | Assura plc Announces Termination of Jayne Marie Cottam as Director, Effective December 16, 2025 | CI |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.64 | 2.51 | 2.56 | 2.82 | 3.12 | |||||
Return on Total Capital | 2.71 | 2.58 | 2.64 | 2.9 | 3.21 | |||||
Return On Equity % | 7.65 | 9.39 | -7.06 | -1.88 | 10.66 | |||||
Return on Common Equity | 7.65 | 9.39 | -7.06 | -1.88 | 10.66 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 92.72 | 92.4 | 91.76 | 90.81 | 90.91 | |||||
SG&A Margin | 9.27 | 8.98 | 9.24 | 8.36 | 8.22 | |||||
EBITDA Margin % | 83.28 | 83.49 | 82.58 | 82.13 | 82.86 | |||||
EBITA Margin % | 83.2 | 83.35 | 82.45 | 81.94 | 82.7 | |||||
EBIT Margin % | 83.2 | 83.35 | 82.45 | 81.94 | 82.7 | |||||
Income From Continuing Operations Margin % | 89.65 | 113.88 | -79.26 | -18.25 | 90.32 | |||||
Net Income Margin % | 89.65 | 113.88 | -79.26 | -18.25 | 90.32 | |||||
Net Avail. For Common Margin % | 89.65 | 113.88 | -79.26 | -18.25 | 90.32 | |||||
Normalized Net Income Margin | 39.01 | 39.31 | 40.18 | 40.48 | 37.61 | |||||
Levered Free Cash Flow Margin | 47.93 | 1.87 | 90.45 | 40.85 | 31.15 | |||||
Unlevered Free Cash Flow Margin | 59.7 | 13.45 | 101.06 | 51.09 | 44.56 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | |||||
Fixed Assets Turnover | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | |||||
Receivables Turnover (Average Receivables) | 7.74 | 8.37 | 8.87 | 7.83 | 8.55 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.34 | 4.64 | 1.95 | 0.89 | 0.73 | |||||
Quick Ratio | 1.09 | 3.6 | 1.92 | 0.83 | 0.6 | |||||
Operating Cash Flow to Current Liabilities | 1.17 | 1.26 | 1.21 | 1.24 | 0.69 | |||||
Days Sales Outstanding (Average Receivables) | 47.14 | 43.59 | 41.14 | 46.74 | 42.7 | |||||
Average Days Payable Outstanding | 207.39 | 133.37 | 47.1 | 31.55 | 40.43 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 62.34 | 69.84 | 78.9 | 85.05 | 94.07 | |||||
Total Debt / Total Capital | 38.4 | 41.12 | 44.1 | 45.96 | 48.47 | |||||
LT Debt/Equity | 62.33 | 69.84 | 78.88 | 85.02 | 89.8 | |||||
Long-Term Debt / Total Capital | 38.4 | 41.12 | 44.09 | 45.95 | 46.27 | |||||
Total Liabilities / Total Assets | 40.14 | 42.65 | 45.68 | 47.62 | 49.95 | |||||
EBIT / Interest Expense | 3.97 | 4.02 | 4.29 | 4.43 | 3.53 | |||||
EBITDA / Interest Expense | 3.98 | 4.02 | 4.3 | 4.44 | 3.53 | |||||
(EBITDA - Capex) / Interest Expense | 3.98 | 4.02 | 4.3 | 4.44 | 3.53 | |||||
Total Debt / EBITDA | 9.49 | 10.94 | 10.09 | 9.67 | 10.14 | |||||
Net Debt / EBITDA | 9.02 | 8.81 | 9.14 | 9.41 | 9.78 | |||||
Total Debt / (EBITDA - Capex) | 9.49 | 10.94 | 10.09 | 9.67 | 10.16 | |||||
Net Debt / (EBITDA - Capex) | 9.02 | 8.81 | 9.14 | 9.41 | 9.8 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.34 | 13.33 | 9.86 | 4.92 | 16.48 | |||||
Gross Profit, 1 Yr. Growth % | 8 | 12.95 | 9.09 | 3.84 | 16.61 | |||||
EBITDA, 1 Yr. Growth % | 7.36 | 13.62 | 8.66 | 4.35 | 17.52 | |||||
EBITA, 1 Yr. Growth % | 7.37 | 13.53 | 8.68 | 4.27 | 17.56 | |||||
EBIT, 1 Yr. Growth % | 7.37 | 13.53 | 8.68 | 4.27 | 17.56 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 37.26 | 43.95 | -176.46 | -75.84 | -676.39 | |||||
Net Income, 1 Yr. Growth % | 37.26 | 43.95 | -176.46 | -75.84 | -676.39 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 24.28 | 37.48 | -171.95 | -75.18 | -625.97 | |||||
Normalized Net Income, 1 Yr. Growth % | 11.7 | 14.19 | 12.31 | 5.69 | 8.22 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 14.74 | 12.18 | -0.56 | -1.21 | 14.4 | |||||
Accounts Receivable, 1 Yr. Growth % | 43.75 | -22.28 | 37.06 | 5.61 | 7.73 | |||||
Total Assets, 1 Yr. Growth % | 15.74 | 22.03 | -6.34 | -3.78 | 16.68 | |||||
Common Equity, 1 Yr. Growth % | 17.53 | 16.91 | -11.29 | -7.21 | 11.49 | |||||
Tangible Book Value, 1 Yr. Growth % | 17.53 | 16.91 | -11.29 | -7.21 | 11.49 | |||||
Cash From Operations, 1 Yr. Growth % | 16.74 | 22.22 | -0.53 | 8.82 | 7.91 | |||||
Capital Expenditures, 1 Yr. Growth % | - | - | - | - | -75 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 69.36 | -95.57 | 5.21K | -52.61 | -9.48 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 46.87 | -74.47 | 725.53 | -46.97 | 3.13 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.75 | 4.23 | 5.41 | 5.13 | 2.44 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.61 | 10.81 | 11.58 | 7.36 | 10.55 | |||||
Gross Profit, 2 Yr. CAGR % | 8.47 | 10.45 | 11 | 6.43 | 10.04 | |||||
EBITDA, 2 Yr. CAGR % | 7.91 | 10.45 | 11.11 | 6.48 | 10.74 | |||||
EBITA, 2 Yr. CAGR % | 7.98 | 10.41 | 11.08 | 6.45 | 10.72 | |||||
EBIT, 2 Yr. CAGR % | 7.98 | 10.41 | 11.08 | 6.45 | 10.72 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 13.55 | 40.57 | 4.91 | -57.02 | 18.01 | |||||
Net Income, 2 Yr. CAGR % | 13.55 | 40.57 | 4.91 | -57.02 | 18.01 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 7.88 | 30.72 | -0.54 | -57.74 | 14.25 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.71 | 12.94 | 13.25 | 8.95 | 6.95 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.66 | 13.45 | 5.62 | -0.89 | 6.31 | |||||
Accounts Receivable, 2 Yr. CAGR % | 43.79 | 5.7 | 3.21 | 20.31 | 6.67 | |||||
Total Assets, 2 Yr. CAGR % | 12.23 | 18.85 | 6.91 | -5.07 | 5.96 | |||||
Common Equity, 2 Yr. CAGR % | 9.36 | 17.22 | 1.84 | -9.27 | 1.71 | |||||
Tangible Book Value, 2 Yr. CAGR % | 9.36 | 17.22 | 1.84 | -9.27 | 1.71 | |||||
Cash From Operations, 2 Yr. CAGR % | 3.04 | 19.45 | 10.26 | 4.04 | 8.36 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 6.43 | -72.62 | 53.28 | 401.56 | -35.12 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 6.17 | -38.76 | 45.18 | 109.24 | -26.6 | |||||
Dividend Per Share, 2 Yr. CAGR % | 2.94 | 3.48 | 4.81 | 5.27 | 3.77 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.95 | 10.16 | 10.49 | 9.32 | 10.32 | |||||
Gross Profit, 3 Yr. CAGR % | 11.78 | 9.94 | 9.99 | 8.56 | 9.72 | |||||
EBITDA, 3 Yr. CAGR % | 11.69 | 9.78 | 9.85 | 8.81 | 10.04 | |||||
EBITA, 3 Yr. CAGR % | 11.76 | 9.8 | 9.83 | 8.76 | 10.03 | |||||
EBIT, 3 Yr. CAGR % | 11.76 | 9.8 | 9.83 | 8.76 | 10.03 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 14.68 | 22.89 | 14.74 | -35.69 | 2.11 | |||||
Net Income, 3 Yr. CAGR % | 14.68 | 22.89 | 14.74 | -35.69 | 2.11 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.67 | 16.96 | 7.13 | -37.38 | -2.07 | |||||
Normalized Net Income, 3 Yr. CAGR % | 15.37 | 10.51 | 12.73 | 10.67 | 8.71 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.49 | 11.83 | 8.57 | 3.29 | 3.97 | |||||
Accounts Receivable, 3 Yr. CAGR % | 26.45 | 17.12 | 15.26 | 4 | 15.96 | |||||
Total Assets, 3 Yr. CAGR % | 12.74 | 15.41 | 9.78 | 3.22 | 1.69 | |||||
Common Equity, 3 Yr. CAGR % | 6.97 | 11.82 | 6.82 | -1.27 | -2.82 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.97 | 11.82 | 6.82 | -1.27 | -2.82 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.76 | 9.07 | 12.38 | 9.78 | 5.32 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 30.88 | -63.13 | 58.46 | 3.64 | 181.67 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 23.37 | -33.98 | 45.74 | 3.78 | 64.46 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.2 | 3.37 | 4.12 | 4.92 | 4.32 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 14.64 | 14 | 11.8 | 9.03 | 10.51 | |||||
Gross Profit, 5 Yr. CAGR % | 13.91 | 13.25 | 11.47 | 8.52 | 10.01 | |||||
EBITDA, 5 Yr. CAGR % | 14.78 | 13.42 | 11.46 | 8.45 | 10.2 | |||||
EBITA, 5 Yr. CAGR % | 14.8 | 13.42 | 11.49 | 8.45 | 10.18 | |||||
EBIT, 5 Yr. CAGR % | 14.8 | 13.42 | 11.49 | 8.45 | 10.18 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 31.16 | 10.34 | 10.67 | -19.27 | 16.04 | |||||
Net Income, 5 Yr. CAGR % | 31.16 | 10.34 | 10.67 | -19.27 | 16.04 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 14.17 | -0.65 | 1.96 | -22.16 | 9.92 | |||||
Normalized Net Income, 5 Yr. CAGR % | 23.35 | 17.28 | 14.52 | 9.88 | 10.38 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.33 | 15.52 | 9.69 | 6.56 | 7.66 | |||||
Accounts Receivable, 5 Yr. CAGR % | 34.37 | 22.9 | 16.59 | 18.39 | 11.74 | |||||
Total Assets, 5 Yr. CAGR % | 17.05 | 17.73 | 10.37 | 6.73 | 8.23 | |||||
Common Equity, 5 Yr. CAGR % | 15.2 | 16.95 | 4.89 | 2.85 | 4.75 | |||||
Tangible Book Value, 5 Yr. CAGR % | 15.2 | 16.95 | 4.89 | 2.85 | 4.75 | |||||
Cash From Operations, 5 Yr. CAGR % | 27.58 | 19.39 | 13.53 | 7.03 | 10.76 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 25.13 | -37.87 | 39.42 | 4.75 | 10.87 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.64 | -14.11 | 31.67 | 4.73 | 10.77 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.22 | 5.18 | 4.45 | 4.12 | 3.98 |
- Stock Market
- Equities
- AGR Stock
- Financials Assura plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















